Meet the Passages Malibu Staff: Chris Prentiss
Meet the Passages Malibu Staff: Chris Prentiss – Chris Prentiss is the co-founder of Passages Malibu and Passages Ventura addiction treatment centers in California. His unique philosophy to treating drug and alcohol addiction is also outlined in his book, “The Alcoholism & Addiction Cure.” Prentiss, along with his son, co-founder and CEO Pax Prentiss, have truly revolutionized addiction treatment by believing that addiction is not a disease. Instead, it’s a symptom of an underlying condition that needs to be discovered and healed. In the wake of Passages Malibu’s 2001 debut (with Passages Ventura following in 2009), many other holistic, non-12 Step treatment centers have tried to copy what we do. But, Passages remains the industry leader in holistic, non-12 Step substance abuse treatment centers. At Passages, we believe in a cure. We believe in you. For more information, please visit www.passagesmalibu.com or call (888) 720-6302.
Multiple Myeloma Research Foundation (MMRF) Celebrates the FDA …
Filed under: drug addiction treatment centers california
Multiple Myeloma Research Foundation (MMRF) Celebrates the FDA Accelerated Approval of Pomalyst® (pomalidomide) for the Treatment of Relapsed and Refractory Multiple Myeloma …. Cancer Center at Hackensack University Medical Center, Mayo Clinic, Mount …
Read more on The Herald | HeraldOnline.com
Promises Treatment Centers Celebrates 25 Years of Creating Extraordinary Lives
Filed under: drug addiction treatment centers california
Promises Treatment Centers in Malibu and West Los Angeles are the premier addiction treatment centers in Southern California. Led by some of the nation's leading addiction specialists, Promises has built an international reputation for innovative …
Read more on PR Newswire (press release)
Scientists Find Key to Growth of 'Bad' Bacteria in Inflammatory Bowel Disease
Filed under: drug addiction treatment centers california
Current treatments for IBD suppress the immune response through antibiotics, corticosteroids or other powerful immune-modifying drugs. But long-term side effects can limit their use and their effectiveness for IBD patients. The UC Davis team's research …
Read more on Science Daily (press release)